GCLC and diabetic retinopathy: Keap1 prevents Nrf2 translocation from the cytosol to the nucleus to bind with ARE4, thereby downregulating the transcription of GCLC and largely attenuating the biosynthesis of GSH, indicating that the Nrf2-Keap1-GCLC pathway plays an important role in diabetic retinopathy [28].